⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Lamivudine (3TC)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-08-27 — A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation: First trial-adjacent entry: lamivudine positioned as an alternative to rapamycin within a feasibility study of exercise + spermidine + drug targeting systemic inflammation — an intent-to-translate signal, not efficacy data. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation
27-aug-2026
novelty 3
per-area 3
strengthens